|
|
INNOVATION AND LEADERSHIP IN ENGINEERING TECHNOLOGIES AND THERAPIES FOR DIABETES |
| 4R90DK098981-05 |
BABENSEE, JULIA E |
NIDDK |
2016 |
|
|
INNOVATION & LEADERSHIP IN ENGINEERING TECHNOLOGIES AND THERAPIES FOR DIABETES |
| 4T90DK097787-05 |
BABENSEE, JULIA E |
NIDDK |
2016 |
|
|
GLYCEMIA REDUCTION APPROACHES IN DIABETES: A COMPARATIVE EFFECTIVENESS STUDY |
| 4U01DK098246-05 |
LACHIN, JOHN M |
NIDDK |
2016 |
|
|
GUT MICROBIOTA AND ATHEROSCLEROSIS IN ESRD |
| 4U01DK099914-04 |
RAJ, DOMINIC S |
NIDDK |
2016 |
|
|
CARDIAC COMPLICATIONS OF HEMODYNAMIC INSTABILITY DURING HEMODIALYSIS |
| 5K23DK102511-02 |
MCCAUSLAND, FINNIAN R |
NIDDK |
2016 |
|
|
THE EFFECTS OF PROTEIN CARBAMYLATION IN END STAGE KIDNEY DISEASE |
| 5K23DK106479-02 |
KALIM, SAHIR |
NIDDK |
2016 |
|
|
UNDERSTANDING AND PREDICTING CARDIAC EVENTS IN HD USING REAL-TIME EHRS |
| 5K25DK097279-05 |
GOLDSTEIN, BENJAMIN ALAN |
NIDDK |
2016 |
|
|
DEVELOPMENTAL PLASTICITY OF MICTURITION REFLEXES |
| 5R01DK060481-10 |
VIZZARD, MARGARET ANN |
NIDDK |
2016 |
|
|
PROSTAGLANDIN BIOSYNTHESIS: A NOVEL THERAPEUTIC TARGET IN TSC DISORDERS |
| 5R01DK098331-03 |
YU, JANE |
NIDDK |
2016 |
|
|
PDE5 INHIBITION OF AFFERENTS AND INTERSTITIAL CELLS IN OVERACTIVE MOUSE BLADDERS |
| 5R01DK098361-03 |
KANAI, ANTHONY JOHN |
NIDDK |
2016 |
